PubMed Health⌕ Search

Biomedical subjects

J Wettlaufer

Publications and source records attributed to J Wettlaufer.

6 recordsLinked to original sources

The jus primae noctis as a male power display. A review of historic sources with evolutionary interpretation.

The jus primae noctis was, in the European late medieval context, a widespread popular belief in an ancient privilege of the lord of the manor to share the wedding bed with his peasants' brides. Symbolic gestures, reflecting this belief, were developed by the lords and used as humiliating signs of superiority over the dependent peasants in the fifteenth century, a time of diminishing status differences. Actual intercourse in the exercise of the alleged right is difficult to prove, and there is no hard evidence to suggest that it ever actually happened. However, the symbolic gestures can be best interpreted as a male power display, with a basis in the psychology of coercive social dominance, male competition, and male desire for sexual variety. Several non-European cultures have accounts of a similar custom related to a young girl's first sexual intercourse: ritual defloration by chiefs, priests, or strangers. This non-European custom differs from the jus primae noctis in its proximate details, but seems from an ultimate point of view, to be in conformity with the European evidence. In this article the origin, development, and relationship of both customs are discussed and interpreted in light of recent evolutionary studies of primate behavior and sexual psychology.

Journal Article↗

Jell-O meds.

Explore the source record for details and available documents.

Administration, Oral↗

Pillow talk.

Explore the source record for details and available documents.

Breathing Exercises↗

Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer.

Seventy-five patients with stage D-2 prostate cancer refractory to orchiectomy have been entered in a controlled trial to test whether androgen priming enhances the efficacy of chemotherapy. All patients are treated with aminoglutethimide and hydrocortisone as a means of achieving medical adrenalectomy and are given cyclic i.v. chemotherapy with cytoxan, adriamycin and 5-fluorouracil. Patients in the stimulation arm (N = 39) receive, in addition, fluoxymesterone (5 mg p.o. b.i.d.) for 3 days before and on the day of chemotherapy. A similar response rate was observed in the stimulation and control arm (83% vs 74% respectively) when the analysis was restricted to evaluable patients. When all patients were included, a significantly higher response rate was observed in the control arm (64% vs 49%, P less than 0.05) as a result of the larger fraction of unevaluable patients in the stimulation arm (41% vs 14%). Median duration of response is 9 months in the stimulation and 10 months in the control arm. Median overall survival in the stimulation and control group is 12 months and 16 months respectively. Significant toxicity consisting of exacerbation of bone pain and, in two patients, development of reversible spinal cord compression was observed following androgen priming. Our results suggest that combined medical adrenalectomy and chemotherapy are highly effective in the treatment of advanced prostate cancer. Thus far, no additional benefit has been observed with androgen priming.

Aminoglutethimide↗